Josep Ribera is Chief of the Clinical Hematology Department and the Stem Cell Transplantation Unit at the Catalan Institute of Oncology University Hospital ‘Germans Trias i Pujol’ in Badalona, Barcelona, Spain. He is also a full Professor of Medicine and Hematology at the Autònoma University of Barcelona. After gaining his medical degree, Professor Ribera specialized in hematology at the Hospital Clínic Barcelona before completing his PhD in the Clinical Hematology Department. Professor Ribera’s main areas of scientific interest include acute lymphoblastic leukemia (ALL) and lymphomas arising in HIV-infected patients. President of the Foundation of the cooperative Spanish Hematology Treatment Program (PETHEMA) and Chairman of the PETHEMA Adult ALL Program, Professor Ribera is a member of the steering committee of the European LeukemiaNet and of the European Working Group for Adult ALL (EWALL) and is a councilor of the European Hematology Association (EHA). He is also vice-director of clinical research at the Josep Carreras Leukemia Research Institute and PI of the ALL research group. He is a reviewer for many hematology and oncology journals, and he has authored or co-authored more than 485 articles in international peer-reviewed journals (H index 60), as well as 100 book chapters on hematology and oncology.